We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current EPIX market cap is 72.8M. The company's latest EPS is USD -0.6430 and P/E is -2.55.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.6M | -10.49M | -8.64M | -7.7M | -9.68M |
| Net Income | -5.96M | -8.99M | -7.24M | -6.36M | -8.53M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.52M | -37.14M | -36.96M | -32.13M | -34.42M |
| Net Income | -23.45M | -36.81M | -35.1M | -26.58M | -28.54M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 144.49M | 137.9M | 132.67M | 128.11M | 122.63M |
| Total Liabilities | 3.81M | 4.43M | 3.8M | 3.51M | 3.87M |
| Total Equity | 140.68M | 133.47M | 128.86M | 124.61M | 118.77M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 80.57M | 198.17M | 169.51M | 149.12M | 128.11M |
| Total Liabilities | 1.33M | 4.16M | 2.39M | 3.5M | 3.51M |
| Total Equity | 79.24M | 194.01M | 167.12M | 145.63M | 124.61M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.79M | -13.6M | -19.35M | -22.72M | -6.47M |
| Investing | 8.23M | 70.74M | 70.77M | 91.79M | -3.93M |
| Financing | 196k | 840k | 865k | 926k | N/A |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.98M | -25.42M | -28.71M | -19.78M | -22.72M |
| Investing | -21.74M | -35.02M | -52.35M | -3.53M | 91.79M |
| Financing | 41.78M | 141.99M | 253k | -68k | 926k |
| Market Cap | 72.8M |
| Price to Earnings Ratio | -2.55 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.7 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 44.39M |
| Average Volume (1 week) | 52.33k |
| Average Volume (1 Month) | 223.69k |
| 52 Week Change | -81.19% |
| 52 Week High | 9.60 |
| 52 Week Low | 1.40 |
| Spread (Intraday) | 0.1 (5.88%) |
| Company Name | ESSA Pharma Inc |
| Address |
suite 3500, the stack, 1133 melville street vancouver, british columbia V6E 4E5 |
| Website | https://www.essapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
